Literature DB >> 29736616

Cardiac MRI for the evaluation of oncologic cardiotoxicity.

Adrián I Löffler1, Michael Salerno2,3,4.   

Abstract

Cancer therapeutics-related cardiac dysfunction (CTRCD) is a well-established adverse effect resulting from a number of cancer therapeutics. Newer immunotherapy has been associated with cardiomyopathy and myocarditis making comprehensive imaging useful for early recognition. Cardiac MRI (CMR) offers a comprehensive evaluation to detect CTRCD. Established guidelines for monitoring left ventricular ejection fraction for potential cardiotoxicity have recently incorporated CMR. We will review the utility of CMR in contemporary evaluation for potential oncologic cardiotoxicity.

Entities:  

Keywords:  Cardiac MRI; cardiac toxicity; cardio-oncology

Mesh：

Substances：

Year:  2018        PMID： 29736616      PMCID： PMC6222005          DOI： 10.1007/s12350-018-1293-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  44 in total

1.  Age related changes of the collagen network of the human heart.

Authors:  C R Gazoti Debessa; L B Mesiano Maifrino; R Rodrigues de Souza
Journal:  Mech Ageing Dev       Date:  2001-07-31       Impact factor: 5.432

2.  The case for CMR.

Authors:  Peter W Shaw; Christopher M Kramer
Journal:  J Nucl Cardiol       Date:  2015-07-08       Impact factor: 5.952

3.  Cardiovascular events, early discontinuation of trastuzumab, and their impact on survival.

Authors:  Shi-Yi Wang; Jessica B Long; Arti Hurria; Cynthia Owusu; Richard M Steingart; Cary P Gross; Jersey Chen
Journal:  Breast Cancer Res Treat       Date:  2014-06-21       Impact factor: 4.872

Review 4.  Short and long term radiation induced cardiovascular disease in patients with cancer.

Authors:  Kirsten Melgaard Nielsen; Birgitte Vrou Offersen; Hanne Melgaard Nielsen; Merete Vaage-Nilsen; Syed Wamique Yusuf
Journal:  Clin Cardiol       Date:  2017-01-31       Impact factor: 2.882

5.  Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.

Authors:  C Tan; H Tasaka; K P Yu; M L Murphy; D A Karnofsky
Journal:  Cancer       Date:  1967-03       Impact factor: 6.860

6.  Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans.

Authors:  Andrew S Flett; Martin P Hayward; Michael T Ashworth; Michael S Hansen; Andrew M Taylor; Perry M Elliott; Christopher McGregor; James C Moon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

7.  Accuracy and feasibility of online 3-dimensional echocardiography for measurement of left ventricular parameters.

Authors:  Carly Jenkins; Jonathan Chan; Lizelle Hanekom; Thomas H Marwick
Journal:  J Am Soc Echocardiogr       Date:  2006-09       Impact factor: 5.251

Review 8.  Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs.

Authors:  Ronny S Jiji; Christopher M Kramer; Michael Salerno
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

9.  Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.

Authors:  Brandon C Drafts; Katie M Twomley; Ralph D'Agostino; Julia Lawrence; Nancy Avis; Leslie R Ellis; Vinay Thohan; Jennifer Jordan; Susan A Melin; Frank M Torti; William C Little; Craig A Hamilton; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2013-05-01

10.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing.

Authors:  Jeanette Schulz-Menger; David A Bluemke; Jens Bremerich; Scott D Flamm; Mark A Fogel; Matthias G Friedrich; Raymond J Kim; Florian von Knobelsdorff-Brenkenhoff; Christopher M Kramer; Dudley J Pennell; Sven Plein; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2013-05-01       Impact factor: 5.364
View more
  11 in total

Review 1.  Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.

Authors:  John Alan Gambril; Aaron Chum; Akash Goyal; Patrick Ruz; Katarzyna Mikrut; Orlando Simonetti; Hardeep Dholiya; Brijesh Patel; Daniel Addison
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

Review 2.  Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer.

Authors:  Iosune Baraibar; Ignacio Melero; Mariano Ponz-Sarvise; Eduardo Castanon
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.606

Review 3.  Imaging of Cancer Immunotherapy: Current Approaches and Future Directions.

Authors:  Mizuki Nishino; Hiroto Hatabu; F Stephen Hodi
Journal:  Radiology       Date:  2018-11-20       Impact factor: 11.105

Review 4.  The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review.

Authors:  Qinchao Wu; Baochen Bai; Chao Tian; Daisong Li; Haichu Yu; Bingxue Song; Bing Li; Xianming Chu
Journal:  Cardiovasc Drugs Ther       Date:  2021-04-13       Impact factor: 3.727

Review 5.  Multimodality Advanced Cardiovascular and Molecular Imaging for Early Detection and Monitoring of Cancer Therapy-Associated Cardiotoxicity and the Role of Artificial Intelligence and Big Data.

Authors:  Jennifer M Kwan; Evangelos K Oikonomou; Mariana L Henry; Albert J Sinusas
Journal:  Front Cardiovasc Med       Date:  2022-03-15

6.  Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-Oncology.

Authors:  Maria Laura Canale; Katia Coviello; Gianluca Solarino; Jacopo Del Meglio; Federico Simonetti; Elio Venturini; Andrea Camerini; Nicola Maurea; Irma Bisceglia; Carlo Tessa; Giancarlo Casolo
Journal:  Front Cardiovasc Med       Date:  2022-03-01

Review 7.  Emerging Challenges of Radiation-Associated Cardiovascular Dysfunction (RACVD) in Modern Radiation Oncology: Clinical Practice, Bench Investigation, and Multidisciplinary Care.

Authors:  Moon-Sing Lee; Dai-Wei Liu; Shih-Kai Hung; Chih-Chia Yu; Chen-Lin Chi; Wen-Yen Chiou; Liang-Cheng Chen; Ru-Inn Lin; Li-Wen Huang; Chia-Hui Chew; Feng-Chun Hsu; Michael W Y Chan; Hon-Yi Lin
Journal:  Front Cardiovasc Med       Date:  2020-02-21

8.  Imaging of tumour response to immunotherapy.

Authors:  Clarisse Dromain; Catherine Beigelman; Chiara Pozzessere; Rafael Duran; Antonia Digklia
Journal:  Eur Radiol Exp       Date:  2020-01-03

9.  Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy.

Authors:  Treya M Long; Channa E Marsh; Lawrence G Dembo; Philip Watson; Karen E Wallman; Thomas S Walwyn; Catherine S Choong; Louise H Naylor
Journal:  Cardiooncology       Date:  2019-08-14

10.  Detection of the Early Cardiotoxic Effects of Doxorubicin-Containing Chemotherapy Regimens in Patients with Breast Cancer through Novel Cardiac Magnetic Resonance Imaging: A Short-term Follow-up.

Authors:  Afsaneh Maddah Safaei; Tara Molanaie Kamangar; Sanaz Asadian; Nahid Rezaeian; Ebrahim Esmati; Kasra Kolahdouzan; Leila Hosseini; Marzieh Lashkari; Fatemeh Jafari; Farnaz Amouzegar Hashemi
Journal:  J Clin Imaging Sci       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.